within Pharmacolibrary.Drugs.C_CardiovascularSystem.C07F_BetaBlockingAgentsOtherCombinations.C07FX03_MetoprololAndAcetylsalicylicAcid;

model MetoprololAndAcetylsalicylicAcid
  extends Pharmacolibrary.Drugs.ATC.C.C07FX03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C07FX03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Fixed combination of metoprolol (a selective beta-1 adrenergic blocker used for hypertension, angina, and heart failure) and acetylsalicylic acid (aspirin, an antiplatelet and anti-inflammatory agent for cardiovascular prevention). Intended to reduce blood pressure and risk of cardiovascular complications, generally for secondary prevention post-myocardial infarction or for cardiovascular risk reduction. This fixed-dose combination is approved in certain regions but not globally available as of 2024.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated from individual component data (metoprolol tartrate and acetylsalicylic acid) in healthy adults, as no published study reports PK parameters for the fixed combination product.</p><h4>References</h4><ol><li><p>Miners, JO (1989). Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid. <i>Clinical pharmacokinetics</i> 17(5) 327–344. DOI:<a href=\"https://doi.org/10.2165/00003088-198917050-00003\">10.2165/00003088-198917050-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2573442/\">https://pubmed.ncbi.nlm.nih.gov/2573442</a></p></li><li><p>Melander, A, &amp; McLean, A (1983). Influence of food intake on presystemic clearance of drugs. <i>Clinical pharmacokinetics</i> 8(4) 286–296. DOI:<a href=\"https://doi.org/10.2165/00003088-198308040-00002\">10.2165/00003088-198308040-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6352137/\">https://pubmed.ncbi.nlm.nih.gov/6352137</a></p></li><li><p>Koya, Y, et al., &amp; Kotegawa, T (2016). Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs. <i>European journal of clinical pharmacology</i> 72(11) 1353–1361. DOI:<a href=\"https://doi.org/10.1007/s00228-016-2102-5\">10.1007/s00228-016-2102-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27491774/\">https://pubmed.ncbi.nlm.nih.gov/27491774</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end MetoprololAndAcetylsalicylicAcid;
